Michael Williams

Michael Williams is a senior pharmaceutical executive with significant global experience. He was chief operating officer at Intarcia Therapeutics. Prior to Intarcia Therapeutics, Mr Williams was head of global marketing at Takeda Pharmaceuticals. Before joining Takeda, he was vice president of global commercial development for Pfizer’s Primary Care Global Business Unit. He also played a significant leadership role in Pfizer’s acquisition of King Pharmaceuticals and on alliances with Bristol Myers Squibb, Boehringer Ingelheim, Janssen and Eisai. During his time at Bristol Myers Squibb, he assumed roles of increasing responsibility, notably as regional business lead for HIV where he was responsible for the commercial performance of the HIV franchise, as well as vice president for European marketing and operations.
Bio last updated 19 May 2018

Article Timeline

Positions - Previous

PositionCompanyYearCompany's current rank
Non-Executive DirectorPhylogica2018 - 2018113

Total Shareholder Return as at 30/04/18

1 year TSR5 year TSR
145thFamily Zone Cyber Safety79%0%
408thKatana Capital6%4%
469thMejority Capital-1%-10%
721 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


121st↓Katana Capital$2.4m
123rd↓Mejority Capital$2.3m
124th↑Family Zone Cyber Safety$2.3m
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer